Neurologic disorders in renal failure (first of two parts).
D001812:Blood-Brain Barrier; D001927:Brain Diseases / Q000209:etiology / Q000503:physiopathology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D003975:Diazepam / Q000627:therapeutic use; D004827:Epilepsy / Q000209:etiology; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009069:Movement Disorders / Q000209:etiology; D009207:Myoclonus / Q000209:etiology; D009422:Nervous System Diseases / Q000209:etiology*; D010672:Phenytoin / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy; D013746:Tetany / Q000209:etiology; D014202:Tremor / Q000209:etiology; D014511:Uremia / Q000134:cerebrospinal fluid / Q000150:complications* / Q000503:physiopathology
D002556:Cerebrospinal Fluid Proteins; D010672:Phenytoin; D008012:Lidocaine; D003975:Diazepam